glp-1 agonists and pancreatitis Updates in Medicine | GLP-1s may raise risk early—but over time, protective effects balance the scale, resulting in no increase in overall 1-year risk Pancreatitis risk from GLP1 use
Description
Glucagon-like peptide-1 (GLP-1) agonists have transformed weight loss treatments
Surgery for weight loss in adults
Changes in blood pressure: Both elevation and reduction have been noted
This is data
